Schering Plough Engineers, Marc Steinman (left), who is also a Ph.D. student at NJIT, and NJIT Alumnus Colin Walters '94, '00, (right), are among the industry advisors who consult with Dr. Piero Armenante (center) on research as well as on the M.S. in Pharmaceutical Engineering program.
Launched in January to address the workforce needs of New Jersey's thriving pharmaceutical industry, NJIT's M.S. in Pharmaceutical Engineering program has already admitted 25 degree candidates. Piero Armenante, distinguished professor of chemical engineering, directs the program, which offers tracks in pharmaceutical operations as well as pharmaceutical production and development. One of only a handful of such programs in the nation, the new course of study has been developed in cooperation with industry and is being enhanced with grant support from the Schering-Plough Foundation and other companies.
Dr. Armenante attributes the program's instant popularity to the increasingly important role that engineers play in the pharmaceutical industry, and the emergence of the pharmaceutical industry as one of the strongest and most exciting sectors of the economy. New Jersey is home to 21 of the world's largest pharmaceutical and medical companies, and Jersey-based firms developed half of the new drugs approved by FDA in last year. The master's curriculum, developed in consultation with industry advisors, prepares technical specialists to work in such areas as drug manufacturing, pharmaceutical development, pharmaceutical production and pharmaceutical operations.